SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-134996
Filing Date
2018-04-26
Accepted
2018-04-26 16:42:56
Documents
5
Period of Report
2018-06-08
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d764354ddef14a.htm DEF 14A 325363
2 GRAPHIC g764354g16s44.jpg GRAPHIC 1678
3 GRAPHIC g764354g30v42.jpg GRAPHIC 58312
4 GRAPHIC g764354g85f57.jpg GRAPHIC 1676
5 GRAPHIC g764354g89o75.jpg GRAPHIC 56399
  Complete submission text file 0001193125-18-134996.txt   489621
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36571 | Film No.: 18779217
SIC: 3841 Surgical & Medical Instruments & Apparatus